Elanco Animal Health (ELAN) Net Margin Growth (3y) (2020 - 2026)
Elanco Animal Health (ELAN) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -3,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,312.00 |
| Mar 31, 2026 | -404.00 |
| Dec 31, 2025 | -1,864.00 |
| Sep 30, 2025 | 334.00 |
| Jun 30, 2025 | 174.00 |
| Mar 31, 2025 | 146.00 |
| Dec 31, 2024 | 866.00 |
| Sep 30, 2024 | 4,489.00 |
| Jun 30, 2024 | 1,190.00 |
| Mar 31, 2024 | 780.00 |
| Dec 31, 2023 | 1,470.00 |
| Sep 30, 2023 | -8,745.00 |
| Jun 30, 2023 | -13.00 |
| Mar 31, 2023 | 1,564.00 |
| Dec 31, 2022 | -428.00 |
| Sep 30, 2022 | -763.00 |
| Jun 30, 2022 | -544.00 |
| Mar 31, 2022 | -15.00 |
| Dec 31, 2021 | -1,149.00 |
| Sep 30, 2021 | -1,746.00 |